Relevium Technologies Inc. engages in the identification, evaluation, and acquisition of assets or businesses in the health and wellness markets. It primarily focuses in the areas of e-commerce and wellness services, as well as on nutraceuticals, sports nutrition, and nutri-cosmeceutical products. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. The company was incorporated in 2012 and is headquartered in Montreal, Canada. Relevium Technologies Inc. is a subsidiary of iTech Medical, Inc.
Industry, Sector and Symbol
Stock Exchange CVE
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolCVE:RLV
CUSIPN/A
Phone+1-514-8248559
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-11.08%
Return on Equity-22.67%
Return on Assets-7.21%
Miscellaneous
EmployeesN/A
Outstanding Shares104,806,000
Market CapC$13.93 million
Relevium Technologies (CVE:RLV) Frequently Asked Questions
What is Relevium Technologies' stock symbol?
Relevium Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RLV."
Who are some of Relevium Technologies' key competitors?
Some companies that are related to Relevium Technologies include InfuSystem (INFU), Retractable Technologies (RVP), Milestone Scientific (MLSS), IsoRay (ISR), Akers Biosciences (AKR), Daxor (DXR), Omega Diagnostics Group (ODX), Vigil Health Solutions (VGL), Iris Biotechnologies (IRSB), SECTOR 10 (SECI), Lifestyle Delivery Systems (LDSYF) and RESMED/IDR UNRESTR (RMD).
Who are Relevium Technologies' key executives?
Relevium Technologies' management team includes the folowing people:
- Mr. Aurelio Useche C.M.A., M.B.A., Pres, CEO & Director (Age 50)
- Mr. Edward Ierfino B. Comm., Mang. of Investor Relations (Age 50)
- Mr. Wayne D. Cockburn, Consultant (Age 61)
- Mr. Faycal Salek, Chief Financial Officer
- Mr. Abis Hussain, Sr. Marketing Officer
Has Relevium Technologies been receiving favorable news coverage?
Press coverage about RLV stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Relevium Technologies earned a daily sentiment score of 0.11 on Accern's scale. They also assigned media coverage about the company an impact score of 46.87 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term. View Recent Headlines for Relevium Technologies.
How do I buy shares of Relevium Technologies?
Shares of RLV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Relevium Technologies' stock price today?
One share of RLV stock can currently be purchased for approximately C$0.12.
How big of a company is Relevium Technologies?
Relevium Technologies has a market capitalization of C$13.93 million.
How can I contact Relevium Technologies?
Relevium Technologies' mailing address is 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada. The company can be reached via phone at +1-514-8248559.
MarketBeat Community Rating for Relevium Technologies (CVE RLV)
MarketBeat's community ratings are surveys of what our community members think about Relevium Technologies and other stocks. Vote "Outperform" if you believe RLV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RLV will underperform the S&P 500 over the long term. You may vote once every thirty days.
